The downgrade reflects Geisinger’s underperformance relative to management’s anticipated margins in 2018, along with Moody’s expectation that rapidly executing multiple large growth strategies and operations of its health plan will continue to weigh on Geisinger’s performance.
The rating outlook has been revised from negative to stable.
More articles on healthcare finance:
Hospitals, not physicians, driving up healthcare costs for privately insured, study shows
Kaiser’s annual revenue grows to $79B
Private equity pushes into healthcare: 9 latest deals
